153 Therapeutics is developing new treatments for Parkinson’s Disease. The company, co-founded by Prof. Pamela England along with UCSF Professor Matthew P. Jacobson and Dr. Peter Noymer, an Executive in Residence at Innovation Ventures, recently negotiated and signed an exclusive license from UCSF for the rights to Dr. England’s intellectual property.
Congratulations to the 153 Therapeutics team!